losmapimod
Showing 1 - 7 of 7
Facioscapulohumeral Muscular Dystrophy (FSHD) Trial in Worldwide (Losmapimod, Placebo oral tablet)
Recruiting
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Losmapimod
- Placebo oral tablet
-
Irvine, California
- +31 more
Jul 28, 2022
Facioscapulohumeral Muscular Dystrophy (FSHD) Trial in Worldwide (Losmapimod, Placebo oral tablet)
Completed
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Losmapimod
- Placebo oral tablet
-
Irvine, California
- +16 more
Feb 8, 2022
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (losmapimod, )
Completed
- Pulmonary Disease, Chronic Obstructive
- losmapimod
- placebo
-
Birmingham, Alabama
- +47 more
Jan 10, 2018
Acute Coronary Syndrome Trial in Baltimore (Losmapimod, Moxifloxacin, Losmapimod matched Placebo)
Completed
- Acute Coronary Syndrome
- Losmapimod
- +3 more
-
Baltimore, MarylandGSK Investigational Site
Jun 6, 2017
Cardiovascular Disease Trial in Cambridge (losmapimod 1 mg, losmapimod, losmapimod 15 mg)
Completed
- Cardiovascular Disease
- losmapimod 1 mg
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Jun 13, 2017
Glomerulosclerosis, Focal Segmental Trial in Canada, United States (Losmapimod)
Completed
- Glomerulosclerosis, Focal Segmental
- Losmapimod
-
Los Angeles, California
- +11 more
May 11, 2017
COPD Trial in Cambridge, London (Losmapimod, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Losmapimod
- Placebo
-
Cambridge, Cambridgeshire, United Kingdom
- +1 more
Mar 15, 2015